|
24890.03.01
|
A-CNOTREN SOFT.CAPS 10MG/CAP BTx30 (σε BLISTERS)
|
|
2,93 |
3,37 |
4,64 |
Pharmathen Investments Group Ltd
|
|
24890.02.01
|
A-CNOTREN SOFT.CAPS 20MG/CAP BTx30 (BLIST(PVC/PE/ /PVDC/ALUM FOIL) 3x10) /PVDC/ALUM FOIL) 3x10)
|
|
5,28 |
6,07 |
8,36 |
Pharmathen Investments Group Ltd
|
|
30407.02.03
|
APILONE CHW.TAB 4MG/TAB BTx14
|
|
2,89 |
3,33 |
4,59 |
Pharmathen Investments Group Ltd
|
|
30407.02.06
|
APILONE CHW.TAB 4MG/TAB BTx30
|
|
5,87 |
6,75 |
9,31 |
Pharmathen Investments Group Ltd
|
|
30407.03.03
|
APILONE CHW.TAB 5MG/TAB BTx14
|
|
2,90 |
3,34 |
4,60 |
Pharmathen Investments Group Ltd
|
|
30407.03.06
|
APILONE CHW.TAB 5MG/TAB BTx30
|
|
6,21 |
7,14 |
9,84 |
Pharmathen Investments Group Ltd
|
|
30407.01.04
|
APILONE F.C.TAB 10MG/TAB BTx14
|
|
2,99 |
3,44 |
4,74 |
Pharmathen Investments Group Ltd
|
|
30407.01.07
|
APILONE F.C.TAB 10MG/TAB BTx30
|
|
6,41 |
7,36 |
10,14 |
Pharmathen Investments Group Ltd
|
|
30830.05.02
|
ARPOYA OR.DISP.TA 10MG/TAB BTx28 tabs σε (PA/Alu/PVC-Alu foil perforated & peel-off blisters (alu-alu blister)
|
|
17,12 |
19,68 |
27,11 |
Pharmathen Investments Group Ltd
|
|
30830.06.02
|
ARPOYA OR.DISP.TA 15MG/TAB BTx28 tabs σε (PA/Alu/PVC-Alu foil perforated & peel-off blisters (alu-alu blister)
|
|
17,30 |
19,89 |
27,41 |
Pharmathen Investments Group Ltd
|
|
30830.07.02
|
ARPOYA OR.DISP.TA 30MG/TAB BTx28 tabs σε (PA/Alu/PVC-Alu foil perforated & peel-off blisters (alu-alu blister)
|
|
30,52 |
35,08 |
48,34 |
Pharmathen Investments Group Ltd
|
|
30830.02.02
|
ARPOYA TAB 10MG/TAB BTx28 tabs σε (PA/Alu foil perforated blisters (alu-alu blister)
|
|
14,68 |
16,88 |
23,26 |
Pharmathen Investments Group Ltd
|
|
30830.03.02
|
ARPOYA TAB 15MG/TAB BTx28 tabs σε (PA/Alu foil perforated blisters (alu-alu blister)
|
|
13,36 |
15,36 |
21,17 |
Pharmathen Investments Group Ltd
|
|
30830.04.02
|
ARPOYA TAB 30MG/TAB BTx28 tabs σε (PA/Alu foil perforated blisters (alu-alu blister)
|
|
25,01 |
28,74 |
39,60 |
Pharmathen Investments Group Ltd
|
|
30830.01.02
|
ARPOYA TAB 5MG/TAB BTx28 tabs σε (PA/Alu foil perforated blisters (alu-alu blister)
|
|
5,41 |
6,22 |
8,58 |
Pharmathen Investments Group Ltd
|
|
27116.03.03
|
DEPREVIX MOD.R.CA.H 150MG/CAP BTx30 (BLIST 3x10)
|
|
5,64 |
6,48 |
8,93 |
Pharmathen Investments Group Ltd
|
|
27116.02.03
|
DEPREVIX MOD.R.CA.H 75MG/CAP BTx30 (BLIST 3 x 10)
|
|
2,85 |
3,27 |
4,51 |
Pharmathen Investments Group Ltd
|
|
32435.04.01
|
DOPELIR INJ.SU.PRO 100MG/PF.SYR BT X 1 PF.SYR + 2 NEEDLES
|
|
127,79 |
146,89 |
180,61 |
Pharmathen Investments Group Ltd
|
|
32435.06.01
|
DOPELIR INJ.SU.PRO 150MG.PF.SYR (BT X 1 PF.SYR X 150MG + 2 NEEDLES) + (BT X 1 PF.SYR X 100MG + 2 NEEDLES) (ΣΥΣΚΕΥΑΣΙΑ ΕΝΑΡΞΗΣ ΘΕΡΑΠΕΙΑΣ)
|
|
274,55 |
305,35 |
356,04 |
Pharmathen Investments Group Ltd
|
|
32435.05.01
|
DOPELIR INJ.SU.PRO 150MG/PF.SYR BT X 1 PF.SYR + 2 NEEDLES
|
|
188,84 |
210,03 |
249,34 |
Pharmathen Investments Group Ltd
|
|
32435.01.01
|
DOPELIR INJ.SU.PRO 25MG/PF.SYR BT X 1 PF.SYR + 2 NEEDLES
|
|
33,44 |
38,43 |
52,96 |
Pharmathen Investments Group Ltd
|
|
32435.02.01
|
DOPELIR INJ.SU.PRO 50MG/PF.SYR BT X 1 PF.SYR + 2 NEEDLES
|
|
66,87 |
76,86 |
97,76 |
Pharmathen Investments Group Ltd
|
|
32435.03.01
|
DOPELIR INJ.SU.PRO 75MG/PF.SYR BT X 1 PF.SYR + 2 NEEDLES
|
|
100,30 |
115,29 |
141,76 |
Pharmathen Investments Group Ltd
|
|
19718.01.01
|
LADININ F.C.TAB 250MG/TAB BTx10 (σε BLISTER)
|
|
1,41 |
1,62 |
2,24 |
Pharmathen Investments Group Ltd
|
|
19718.02.01
|
LADININ F.C.TAB 500MG/TAB BTx10 (σε BLISTER)
|
|
2,82 |
3,24 |
4,46 |
Pharmathen Investments Group Ltd
|
|
19718.06.02
|
LADININ F.C.TAB 750MG/TAB BTx20
|
|
6,58 |
7,56 |
10,42 |
Pharmathen Investments Group Ltd
|
|
19718.04.01
|
LADININ SOL.INF 200MG/100ML VIAL BTx1 VIAL
|
|
3,97 |
4,56 |
6,29 |
Pharmathen Investments Group Ltd
|
|
19718.05.01
|
LADININ SOL.INF 400MG/200ML BT x 1 VIAL x 200 ML
|
|
6,81 |
7,83 |
10,79 |
Pharmathen Investments Group Ltd
|
|
01078.06.02
|
LANOMYCIN INJ.SOL 500MG/2ML AMP BTX10AMPX2ML
|
|
23,38 |
26,88 |
37,04 |
Pharmathen Investments Group Ltd
|
|
28112.03.06
|
LEVOFLOXACIN/ΦΑΡΜΑΤΕΝ SOL.INF 5MG/ML BTx20(VIAL x100 ML)
|
|
154,27 |
177,32 |
214,27 |
Pharmathen Investments Group Ltd
|
|
28091.02.02
|
MARIPRAX TAB 0,18MG/TAB BTx100 (Blister 10x10), (PA/Alu/PVC/Alu) (Blister 10x10), (PA/Alu/PVC/Alu)
|
|
6,90 |
7,93 |
10,93 |
Pharmathen Investments Group Ltd
|
|
28091.03.02
|
MARIPRAX TAB 0,7MG/TAB BTx100 (Blister 10x10), (PA/Alu/PVC/Alu) (Blister 10x10), (PA/Alu/PVC/Alu)
|
|
27,41 |
31,50 |
43,41 |
Pharmathen Investments Group Ltd
|
|
30555.02.03
|
MEGAZON PR.TAB 150MG/TAB BTx30 σε PVC/PCTFE-Aluminium Foil Blisters
|
|
9,24 |
10,62 |
14,64 |
Pharmathen Investments Group Ltd
|
|
30555.03.03
|
MEGAZON PR.TAB 200MG/TAB BTx30 σε PVC/PCTFE-Aluminium Foil Blisters
|
|
5,89 |
6,77 |
9,33 |
Pharmathen Investments Group Ltd
|
|
30555.04.03
|
MEGAZON PR.TAB 300MG/TAB BTx30 σε PVC/PCTFE-Aluminium Foil Blisters
|
|
13,25 |
15,23 |
20,99 |
Pharmathen Investments Group Ltd
|
|
30555.05.03
|
MEGAZON PR.TAB 400MG/TAB BTx30 σε PVC/PCTFE-Aluminium Foil Blisters
|
|
17,37 |
19,96 |
27,51 |
Pharmathen Investments Group Ltd
|
|
30555.01.03
|
MEGAZON PR.TAB 50MG/TAB BTx30 σε PVC/PCTFE-Aluminium Foil Blisters
|
|
2,29 |
2,63 |
3,63 |
Pharmathen Investments Group Ltd
|
|
28220.01.01
|
OZAPEX F.C.TAB 5MG/TAB BTx28 TABS
|
|
9,60 |
11,04 |
15,21 |
Pharmathen Investments Group Ltd
|
|
28220.07.01
|
OZAPEX OR.DISP.TA 10MG/TAB BTx28 TABS
|
|
17,08 |
19,64 |
27,06 |
Pharmathen Investments Group Ltd
|
|
28220.08.01
|
OZAPEX OR.DISP.TA 15MG/TAB BTx28 TABS
|
|
25,50 |
29,31 |
40,39 |
Pharmathen Investments Group Ltd
|
|
28220.09.01
|
OZAPEX OR.DISP.TA 20MG/TAB BTx28 TABS
|
|
41,82 |
48,07 |
66,24 |
Pharmathen Investments Group Ltd
|
|
28220.06.01
|
OZAPEX OR.DISP.TA 5MG/TAB BTx28 TABS
|
|
9,97 |
11,47 |
15,80 |
Pharmathen Investments Group Ltd
|
|
28220.10.01
|
OZAPEX PD.INJ.SOL 10MG/VIAL BTx1 VIAL
|
|
1,87 |
2,15 |
2,97 |
Pharmathen Investments Group Ltd
|
|
26975.01.05
|
PROHYPE F.C.TAB 5MG/TAB BT x 30 (BLIST 2x15)
|
|
4,70 |
5,40 |
7,44 |
Pharmathen Investments Group Ltd
|
|
30299.02.04
|
RATICE F.C.TAB 10MG/TAB ΒΤx30 (σε Blister Triplex) (σε Blister Triplex)
|
|
4,93 |
5,66 |
7,80 |
Pharmathen Investments Group Ltd
|
|
30299.03.04
|
RATICE F.C.TAB 15MG/TAB ΒΤx30 (σε Blister Triplex) (σε Blister Triplex)
|
|
6,12 |
7,04 |
9,70 |
Pharmathen Investments Group Ltd
|
|
30299.04.04
|
RATICE F.C.TAB 20MG/TAB ΒΤx30 (σε Blister Triplex) (σε Blister Triplex)
|
|
9,36 |
10,76 |
14,83 |
Pharmathen Investments Group Ltd
|
|
20777.02.01
|
STABILANOL CAPS 100MG/CAP BTX7(BLIST1X7)
|
|
5,36 |
6,16 |
8,49 |
Pharmathen Investments Group Ltd
|
|
20777.03.02
|
STABILANOL CAPS 150MG/CAP BTX7(BLISTER)
|
|
6,62 |
7,61 |
10,48 |
Pharmathen Investments Group Ltd
|
|
20777.05.01
|
STABILANOL CAPS 200MG/CAP BT x 7 CAPS(BLISTER)
|
|
8,75 |
10,06 |
13,86 |
Pharmathen Investments Group Ltd
|
|
20777.04.01
|
STABILANOL SOL.INF 100MG/50ML VIAL BT x 1 VIAL
|
|
2,28 |
2,62 |
3,61 |
Pharmathen Investments Group Ltd
|
|
30309.03.01
|
TAMVELIER EY.DRO.SOL 5MG/ML BTx1 BOTTLEx5 ML
|
|
2,67 |
3,07 |
4,23 |
Pharmathen Investments Group Ltd
|
|
30309.01.03
|
TAMVELIER F.C.TAB 400MG/TAB BTx7 (PA/ALL/PVC)
|
|
5,55 |
6,38 |
8,79 |
Pharmathen Investments Group Ltd
|
|
30309.02.01
|
TAMVELIER SOL.INF 400MG/250ML BTx1 BOTTLE x 250ML
|
|
9,14 |
10,51 |
14,48 |
Pharmathen Investments Group Ltd
|
|
27807.02.02
|
TRONDAMET F.C.TAB 8MG/TAB BT x 15 (BLIST 1x15)
|
|
14,13 |
16,24 |
22,38 |
Pharmathen Investments Group Ltd
|
|
27807.02.04
|
TRONDAMET F.C.TAB 8MG/TAB BT x 50 (BLIST 5x10)
|
|
41,43 |
47,62 |
65,62 |
Pharmathen Investments Group Ltd
|
|
27807.03.01
|
TRONDAMET SO.INJ.INF 2MG/ML BT x 5 (AMPS x 2 ML)
|
|
11,64 |
13,38 |
18,43 |
Pharmathen Investments Group Ltd
|
|
27807.03.03
|
TRONDAMET SO.INJ.INF 2MG/ML BT x 5 (AMPS x 4ML)
|
|
13,71 |
15,76 |
21,72 |
Pharmathen Investments Group Ltd
|
